Merck Animal Health Acquires U.S. Rights to SENTINEL Brand
Merck Animal Health acquired the U.S. rights to SENTINEL FLAVOR TABS and SENTINE SPECTRUM Chews in the companion animal category from Virbac.
The acquisition complements Merck Animal Health’s portfolio of vaccines and pharmaceuticals.
“Our veterinary medicines, including parasiticides, and vaccines continue to transform the animal health industry and further solidify our position in the U.S. Companion Animal category,” said Rick DeLuca, president, Merck Animal Health. “The extensive breadth and depth of our product portfolio enhances our offerings of comprehensive pet care solutions, which provide a full range of complementary solutions for our customers to improve the health and well-being of animals and the people who care for them.”